Merck nears $10 billion deal for respiratory drugmaker Verona, FT reports-February 2024-www.financetom.com

Merck nears $10 billion deal for respiratory drugmaker Verona, FT reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Merck nears $10 billion deal for respiratory drugmaker Verona, FT reports

Jul 8, 2025 10:19 PM

(Reuters) -Merck is nearing a roughly $10 billion deal to buy lung disease-focused biotech Verona Pharma, the Financial Times reported on Wednesday.

Merck would pay $107 per American depository share for Verona, the report said, citing three people familiar with the matter.

Reuters couldn't immediately verify the report.

(Reporting by Kanjyik Ghosh in Bengaluru; Editing by Mrigank Dhaniwala)

Previous page： Xi's trip to Europe may lay bare West's divisions over China strategy Next page： Sector Update: Consumer Stocks Mixed Pre-Bell Thursday

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Xi's trip to Europe may lay bare West's divisions over China strategy

May 2, 2024

* China's Xi makes first visit to Europe in five years * EU states differ on China strategy, weakening bloc's leverage * EU threatens tariffs on China EV vehicles, green tech * Paris, Brussels readier than Berlin to push back on subsidies * Xi's Serbia, Hungary trips seen as move to deepen EU rifts By Laurie Chen and Michel Rose...

Sector Update: Consumer Stocks Mixed Pre-Bell Thursday

May 2, 2024

09:10 AM EDT, 05/02/2024 (MT Newswires) -- Consumer stocks were mixed pre-bell Thursday with the Consumer Staples Select Sector SPDR Fund ( XLP ) recently inactive and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) 0.9% higher. Etsy ( ETSY ) was down more than 15% after it reported Q1 net income of $0.48 per diluted share, down...

Huntington Ingalls Industries Q1 Earnings, Revenue Increase

May 2, 2024

09:14 AM EDT, 05/02/2024 (MT Newswires) -- Huntington Ingalls Industries ( HII ) reported Q1 earnings Thursday of $3.87 per diluted share, up from $3.23 a year earlier. Analysts polled by Capital IQ expected $3.52. Revenue for the quarter ended March 31 was $2.81 billion, up from $2.67 billion a year earlier. Analysts surveyed by Capital IQ expected $2.79 billion....

Kimco Realty Q1 FFO Flat, Revenue Climbs; Raises 2024 Outlook

May 2, 2024

09:11 AM EDT, 05/02/2024 (MT Newswires) -- Kimco Realty ( KIM ) reported Q1 funds from operations Thursday of $0.39 per diluted share, unchanged from a year earlier. Analysts surveyed by Capital IQ expected $0.37. Revenue for the quarter ended March 31 was $503.8 million, up from $442.9 million a year earlier. Analysts polled by Capital IQ expected $452.8 million....